← FDA DRUG APPROVALS

FDA ANDA · ANDA214295

URSODIOL

Sponsor: ZYDUS LIFESCIENCES

APPLICATION
ANDA214295
TYPE
ANDA
ORIGINAL APPROVAL
2020-10-16
LATEST ACTION
2023-09-13
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

URSODIOLPrescription
URSODIOL 300MG · CAPSULE · ORAL

Approval history

2023-09-13Labeling · Supplement 1 · standardAP
2020-10-16UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →